365
Views
22
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy of Tiotropium Inhalation Powder in African-American Patients with Chronic Obstructive Pulmonary Disease

, , , , , & show all
Pages 35-41 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Andrea S Melani. (2015) Long-acting muscarinic antagonists. Expert Review of Clinical Pharmacology 8:4, pages 479-501.
Read now
David MG Halpin, Ronald Dahl, Christoph Hallmann, Achim Mueller & Donald Tashkin. (2015) Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 239-259.
Read now
Marc Miravitlles, David Price, Klaus F Rabe, Hendrik Schmidt, Norbert Metzdorf & Bartolome Celli. (2015) Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 549-564.
Read now
Amir Sharafkhaneh, Hashir Majid & Nicholas J Gross. (2013) Safety and tolerability of inhalational anticholinergics in COPD. Drug, Healthcare and Patient Safety 5, pages 49-55.
Read now
Donald A. Mahler, Joseph Ward, Laurie A. Waterman & John C. Baird$suffix/text()$suffix/text(). (2012) Longitudinal Changes in Patient-reported Dyspnea in Patients with COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 9:5, pages 522-527.
Read now
Umair Gauhar, Mark Dransfield & J Allen D Cooper. (2009) Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting. International Journal of Chronic Obstructive Pulmonary Disease 4, pages 391-395.
Read now
Steven Kesten, Bart Celli, Marc Decramer, Inge Leimer & Donald Tashkin. (2009) Tiotropium HandiHaler® in the treatment of COPD: A safety review. International Journal of Chronic Obstructive Pulmonary Disease 4, pages 397-409.
Read now
Yuji Oba, Tareq Zaza & Danish M Thameem. (2008) Safety, tolerability and risk benefit analysis of tiotropium in COPD. International Journal of Chronic Obstructive Pulmonary Disease 3:4, pages 575-584.
Read now

Articles from other publishers (14)

Chuchu Zhang, Meng Zhang, Yalei Wang, Huaiyu Xiong, Qiangru Huang, Tiankui Shuai & Jian Liu. (2023) Efficacy and Cardiovascular Safety of LAMA in Patients with COPD: A Systematic Review and Meta-Analysis. Journal of Investigative Medicine 69:8, pages 1391-1398.
Crossref
Mario Cazzola, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2016) Tiotropium formulations and safety: a network meta-analysis. Therapeutic Advances in Drug Safety 8:1, pages 17-30.
Crossref
Alexandros G. MathioudakisProdromos KanavidisVictoria Chatzimavridou-GrigoriadouIoannis P. GialmanidisStavroula G. AmanetopoulouEleni ChristopoulouEfstathia EvangelopoulouGeorgios A. Mathioudakis. (2014) Tiotropium HandiHaler Improves the Survival of Patients with COPD: A Systematic Review and Meta-Analysis. Journal of Aerosol Medicine and Pulmonary Drug Delivery 27:1, pages 43-50.
Crossref
Shannon Cope, James F Donohue, Jeroen P Jansen, Matthias Kraemer, Gorana Capkun-Niggli, Michael Baldwin, Felicity Buckley, Alexandra Ellis & Paul Jones. (2013) Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis. Respiratory Research 14:1.
Crossref
MeiLan K. Han, Douglas Curran-Everett, Mark T. Dransfield, Gerard J. Criner, Lening Zhang, James R. Murphy, Nadia N. Hansel, Dawn L. DeMeo, Nicola A. Hanania, Elizabeth A. Regan, Barry J. Make, Fernando J. Martinez, Gloria E. Westney & Marilyn G. Foreman. (2011) Racial Differences in Quality of Life in Patients With COPD. Chest 140:5, pages 1169-1176.
Crossref
Ana Maria Baptista Menezes, Silvia Elaine Cardozo Macedo, Ricardo Bica Noal, Jussara Fiterman, Alberto Cukier, José Miguel Chatkin & Frederico Leon Arrabal Fernandes. (2011) Tratamento farmacológico da DPOC. Jornal Brasileiro de Pneumologia 37:4, pages 527-543.
Crossref
Donald P Tashkin. (2010) Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Current Opinion in Pulmonary Medicine 16:2, pages 97-105.
Crossref
Bartolome Celli, Marc Decramer, Inge Leimer, Ulrich Vogel, Steven Kesten & Donald P. Tashkin. (2010) Cardiovascular Safety of Tiotropium in Patients With COPD. Chest 137:1, pages 20-30.
Crossref
. (2009) Tiotropium-Lessons from recent studies. Respirology 14:5, pages 623-624.
Crossref
Qibiao WU, Guochun LI, Wun I. LEI & Xiqiao ZHOU. (2009) The efficacy and safety of tiotropium in Chinese patients with stable chronic obstructive pulmonary disease: A meta-analysis. Respirology 14:5, pages 666-674.
Crossref
. (2009) Current World Literature. Current Opinion in Pulmonary Medicine 15:2, pages 170-177.
Crossref
deNay P Kirkpatrick & Mark T Dransfield. (2009) Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Current Opinion in Pulmonary Medicine 15:2, pages 100-104.
Crossref
Trevor T. Hansel, Andrew J. Tan, Peter J. Barnes & Onn Min Kon. 2009. Asthma and COPD. Asthma and COPD 615 626 .
Kathryn L. Rice, Inge Leimer, Steven Kesten & Dennis E. Niewoehner. (2008) Responses to tiotropium in African-American and Caucasian patients with chronic obstructive pulmonary disease. Translational Research 152:2, pages 88-94.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.